US68906L1052 - OTIC - A119VZ (XNMS)
OTONOMY INC Aktie
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | 0,00 % | -99,61 % |
Firmenprofil zu OTONOMY INC Aktie
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurotrophic factor that is in Phase IIa clinical trials for the repair of cochlear synaptopathy and the treatment of speech-in-noise hearing difficulties. It also develops OTO-510, an otoprotectant for the prevention of cisplatin-induced hearing loss; OTO-825, a gene therapy for the treatment of congenital hearing loss; and OTO-6XX induces hair cell repair and regeneration for the treatment of severe hearing loss. The company has license agreements with University of California and DURECT Corporation; and strategic collaboration with Applied Genetic Technologies Corporation to develop and commercialize gene therapy for congenital hearing loss. Otonomy, Inc. was incorporated in 2008 and is headquartered in San Diego, California.
Unternehmensdaten zur OTONOMY INC Aktie
Name OTONOMY INC
Firma Otonomy, Inc.
Symbol OTIC
Website https://www.otonomy.com
Heimatbörse
NASDAQ/NMS (GLOBAL MARKET)
WKN A119VZ
ISIN US68906L1052
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Mr. David M. Maggio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,1 T
Adresse 4796 Executive Drive, 92121 San Diego
IPO Datum 2014-08-13
Dividenden von OTONOMY INC
Ex-Datum | Dividende pro Aktie |
---|---|
11.04.2023 | 0,11 USD |
Ticker Symbole
Name | Symbol |
---|---|
NASDAQ | OTIC |
Weitere Aktien
Investoren die OTONOMY INC halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024